(Q38396441)

2 September 2017

title

Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer (English)

1 reference

2 September 2017

1 reference

Jun-Jun Qiu

1

1 reference

2 September 2017

Jun-Jie Guo

2

1 reference

2 September 2017

Tian-Jiao Lv

3

1 reference

2 September 2017

Hong-Yan Jin

4

1 reference

2 September 2017

Jing-Xin Ding

5

1 reference

2 September 2017

Wei-Wei Feng

6

1 reference

2 September 2017

Ying Zhang

7

1 reference

2 September 2017

Ke-Qin Hua

8

1 reference

2 September 2017

language of work or name

1 reference

28 May 2013

1 reference

2 September 2017

1 reference

2 September 2017

volume

34

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

2971-2975

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-0860-6

2 September 2017

exact match

0 references

cites work

Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Centromere identity maintained by nucleosomes assembled with histone H3 containing the CENP-A targeting domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Expression and prognostic significance of centromere protein A in human lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Breast-feeding and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0860-6

Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23712606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23712606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23712606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-0860-6

1 reference

Dimensions Publication ID

2 September 2017

1008874500

0 references

1 reference